Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure

Objective: To explore the possible mechanism of Yi Xin Tai Formula (YXTF) in treating heart failure (HF) by network pharmacology method and to verify the related targets by western blotting. Methods: Using the traditional Chinese medicine systems pharmacology (TCMSP) database with its analysis platf...

Full description

Bibliographic Details
Main Authors: Wei Jia-Ming, Zhu Jun-Ping, Zhang Tong-Yu, Li Yu-Ying, Kuang Lin, Guo Zhi-Hua, Li Ya
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2019-12-01
Series:Digital Chinese Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589377720300069
id doaj-9f857abfe0244cf98cd01aa66eb00e4e
record_format Article
spelling doaj-9f857abfe0244cf98cd01aa66eb00e4e2020-11-25T03:07:38ZengKeAi Communications Co., Ltd.Digital Chinese Medicine2589-37772019-12-0124237256Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart FailureWei Jia-Ming0Zhu Jun-Ping1Zhang Tong-Yu2Li Yu-Ying3Kuang Lin4Guo Zhi-Hua5Li Ya6Hunan University of Chinese Medicine, Changsha, Hunan, 410208, ChinaShenzhen Pingle Hospital of Orthopedics and Traumatology, Shenzhen Pingshan Chinese Medicine Hospital, Shenzhen, Guangdong 518001, ChinaHunan University of Chinese Medicine, Changsha, Hunan, 410208, ChinaHunan University of Chinese Medicine, Changsha, Hunan, 410208, ChinaHunan University of Chinese Medicine, Changsha, Hunan, 410208, ChinaHunan University of Chinese Medicine, Changsha, Hunan, 410208, China; Corresponding author. Research direction: Prevention and treatment of cardiovascular and cerebrovascular diseases.Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China; Corresponding author. Research direction: cardiovascular pharmacology and pharmaceutics of TCM.Objective: To explore the possible mechanism of Yi Xin Tai Formula (YXTF) in treating heart failure (HF) by network pharmacology method and to verify the related targets by western blotting. Methods: Using the traditional Chinese medicine systems pharmacology (TCMSP) database with its analysis platform for HF as a disease model, the active ingredients of YXTF were filtered according to the oral bioavailability (OB) and drug- likeness (DL), and the corresponding targets were predicted. The disease targets of HF were retrieved by Human Phenotype Ontology (HPO) database. Then, “YXTF compounds - Targets - HF” network was constructed in the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, the network visualized through the Cytoscape software, and the key nodes of the network achieved according to Degree (D), Closeness Centrality (CC), and Betweenness Centrality (BC). Kyoto Encyclopedia of Genes and Genomes (KEGG) gene function enrichment analysis was carried out for the key nodes with the help of GATHER database platform. The rabbit model of HF was established by coarctation of the abdominal aorta and perfusion of propylthiouracil (PTU). The pathological changes and protein expression of transforming growth factor beta (TGF-β) protein were observed by western blotting. Results: “YXTF compounds - Targets - HF” network consisted of 403 nodes, 136 key nodes and 10 related KEGG pathways that included focal adhesions, cell cycles, mitogen-activated protein kinase (MAPK) signaling pathways, Toll-like receptor signaling pathways, Cytokine-cytokine receptor interactions, Gap junctions, adherens junctions, TGF-β signaling pathways, apoptosis and Wnt signaling pathways, respectively. The expression of TGF-β protein in myocardium decreased significantly. Conclusions: According to the network pharmacology, the treatment of YXTF for HF might be related to 10 metabolic pathways. The effects of the multicompound-multitarget-multi pathways and the synergistic effect drawn from the compounds that act as the monarch, minister, adjuvant, guide medicines were revealed through this study. Keywords: Yi Xin Tai Formula (YXTF), Heart failure (HF), Network pharmacology, Western blotting, TGF-β signal pathwayhttp://www.sciencedirect.com/science/article/pii/S2589377720300069
collection DOAJ
language English
format Article
sources DOAJ
author Wei Jia-Ming
Zhu Jun-Ping
Zhang Tong-Yu
Li Yu-Ying
Kuang Lin
Guo Zhi-Hua
Li Ya
spellingShingle Wei Jia-Ming
Zhu Jun-Ping
Zhang Tong-Yu
Li Yu-Ying
Kuang Lin
Guo Zhi-Hua
Li Ya
Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
Digital Chinese Medicine
author_facet Wei Jia-Ming
Zhu Jun-Ping
Zhang Tong-Yu
Li Yu-Ying
Kuang Lin
Guo Zhi-Hua
Li Ya
author_sort Wei Jia-Ming
title Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
title_short Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
title_full Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
title_fullStr Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
title_full_unstemmed Application of Network Pharmacology to Explore the Mechanism of Yi Xin Tai Formula in Treating Heart Failure
title_sort application of network pharmacology to explore the mechanism of yi xin tai formula in treating heart failure
publisher KeAi Communications Co., Ltd.
series Digital Chinese Medicine
issn 2589-3777
publishDate 2019-12-01
description Objective: To explore the possible mechanism of Yi Xin Tai Formula (YXTF) in treating heart failure (HF) by network pharmacology method and to verify the related targets by western blotting. Methods: Using the traditional Chinese medicine systems pharmacology (TCMSP) database with its analysis platform for HF as a disease model, the active ingredients of YXTF were filtered according to the oral bioavailability (OB) and drug- likeness (DL), and the corresponding targets were predicted. The disease targets of HF were retrieved by Human Phenotype Ontology (HPO) database. Then, “YXTF compounds - Targets - HF” network was constructed in the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, the network visualized through the Cytoscape software, and the key nodes of the network achieved according to Degree (D), Closeness Centrality (CC), and Betweenness Centrality (BC). Kyoto Encyclopedia of Genes and Genomes (KEGG) gene function enrichment analysis was carried out for the key nodes with the help of GATHER database platform. The rabbit model of HF was established by coarctation of the abdominal aorta and perfusion of propylthiouracil (PTU). The pathological changes and protein expression of transforming growth factor beta (TGF-β) protein were observed by western blotting. Results: “YXTF compounds - Targets - HF” network consisted of 403 nodes, 136 key nodes and 10 related KEGG pathways that included focal adhesions, cell cycles, mitogen-activated protein kinase (MAPK) signaling pathways, Toll-like receptor signaling pathways, Cytokine-cytokine receptor interactions, Gap junctions, adherens junctions, TGF-β signaling pathways, apoptosis and Wnt signaling pathways, respectively. The expression of TGF-β protein in myocardium decreased significantly. Conclusions: According to the network pharmacology, the treatment of YXTF for HF might be related to 10 metabolic pathways. The effects of the multicompound-multitarget-multi pathways and the synergistic effect drawn from the compounds that act as the monarch, minister, adjuvant, guide medicines were revealed through this study. Keywords: Yi Xin Tai Formula (YXTF), Heart failure (HF), Network pharmacology, Western blotting, TGF-β signal pathway
url http://www.sciencedirect.com/science/article/pii/S2589377720300069
work_keys_str_mv AT weijiaming applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT zhujunping applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT zhangtongyu applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT liyuying applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT kuanglin applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT guozhihua applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
AT liya applicationofnetworkpharmacologytoexplorethemechanismofyixintaiformulaintreatingheartfailure
_version_ 1724669298549456896